SAR443765 / LUNSEKIMIG
Sponsors
Sanofi-Aventis Recherche & Developpement
Conditions
AsthmaChronic rhinosinusitis with nasal polyps
Phase 2
A single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) who completed a previous lunsekimig CRSwNP clinical study
RecruitingCTIS2024-515912-27-00
Start: 2025-12-08Target: 25Updated: 2025-06-16
An open label extension study to evaluate the long-term safety and efficacy of subcutaneous lunsekimig in adult participants with asthma who participated in study DRI16762 or ACT18301
Not yet recruitingCTIS2025-522896-27-00
Target: 36Updated: 2026-03-03